Skip to main content
Home

Main navigation

  • About HIPRA

      About HIPRA

    • Discover HIPRA
    • History
    • Sustainability & CSR
    • HIPRA Around the World
  • Animal Health

      Animal Health

    • Products
      • Vaccines
      • Diagnostic kits
      • Pharmaceuticals
    • Services
      • About Smart Vaccination
      • HIPRASTATS
      • HIPRA Diagnos
      • HIPRA University
      • Online Calculators
    • Knowledge
    • News
    • Solutions for
      • Swine
      • Poultry
      • Cattle
      • Sheep and goats
      • Rabbits
      • Fish
      • Dogs
  • Human Health

      Human Health

    • Products
      • Covid-19 Vaccine
      • GoodGut: digestive health
    • R&D projects
    • News
    • Press
  • Careers
  • Contact us
Career
Search
Search

Press

who we are
Press
03/11/2022 - 10:00

AEMPS authorizes Phase IIb second clinical trial of the HIPRA’s vaccine against Covid-19

Human
Explore
02/01/2022 - 15:33

AEMPS authorizes phase III clinical trial of the HIPRA’s vaccine against Covid-19

Human
Explore
01/20/2022 - 15:55

The European RBDCOV project will study HIPRA’s Covid-19 vaccine in children, adolescents and immunocompromised patients

Human
Explore
01/13/2022 - 15:50

AEMPS authorizes Phase IIb clinical trial of HIPRA Covid-19 vaccine

Human
Explore
12/20/2021 - 09:15

HIPRA’s Covid-19 vaccine shows an effective immunological response with no adverse effects in preclinical trials

Human
Explore
09/13/2021 - 18:48

HIPRA signs an agreement to supply 50 millions doses of Covid-19 vaccine to Vietnam

Human
Explore
  • Load More
Home

Footer second

  • About HIPRA
  • Animal Health
  • Human Health

Footer third

  • Careers
  • Contact us

Footer fourth

  • LinkedIn
  • YouTube

Footer

  • Terms of use
  • Privacy policy
  • Cookies policy